Skip to main content
Springer logoLink to Springer
. 2026 Mar 9;36(2):223–232. doi: 10.1007/s10286-026-01191-7

Impaired attention and cognitive deficits associated with pain and autonomic symptoms in hypermobile Ehlers-Danlos syndrome: a pilot study

Katharina Müller 1,3, Joana C Thiel 4, Lena Schopen 1, Bruno Fimm 1, Jörg B Schulz 1,2, Andrea Maier 1,
PMCID: PMC13068739  PMID: 41801611

Abstract

Purpose

Patients with hypermobile Ehlers-Danlos syndrome (hEDS) frequently present with circulatory dysfunction, including postural orthostatic tachycardia syndrome (POTS), and cognitive impairments, leading to substantial disability and limitations in daily functioning. Few studies have examined attention, and concentration and associated conditions in hEDS. In this case–control study, we used a comprehensive cognitive test battery to assess whether cognitive performance is impaired in individuals with hEDS and depends on different body positions.

Methods

Twenty-nine patients and 29 healthy controls (HC) were enrolled. Baseline cognitive assessments included the Performance Scale of an intelligence test (LPS), Montreal Cognitive Assessment (cognitive deficit screening), and Test of Attentional Performance (TAP). The main cognitive tests for assessing the effects of body position were conducted in randomized conditions (supine, standing, and standing legs-crossed) and included the Stroop test, Corsi block-tapping test, Trail Making Test Part B, and Wechsler Memory Scale-revised.

Results

Compared to HC, patients with hEDS had higher intellectual performance (p < .050), but besides relevant comorbid conditions, also significantly impaired attention in the TAP (p < .010) and an impairment of executive function assessed by the Stroop test (p < .010) in the legs-crossed compared to the supine position.

Conclusion

Attention in the hEDS group was impaired compared to HC, and executive performance was dependent on body position. Individuals performed worse when standing legs-crossed. Hence, impaired proprioception as present in hEDS may, along with comorbid conditions such as pain, be a contributing factor affecting executive function.

Keywords: Hypermobile Ehlers-Danlos syndrome (hEDS), Postural orthostatic tachycardia syndrome (POTS), Cognitive impairment, Executive function, Coordination, Proprioception

Introduction

Ehlers-Danlos syndromes (EDS) are rare, congenital disorders comprising a heterogeneous group of hereditary connective tissue disorders. Among the 13 recognized subtypes, the hypermobile type (hEDS) is the most common subtype and mostly affects women. hEDS is characterized by hypermobility of the joints, mild hyperextensibility of the skin, and fragility of the tissues [13]. Muscles, ligaments, joints, internal organs, and blood vessels may be affected in this condition [1]. Besides typical symptoms of joint dislocations and pain, patients with hEDS often express difficulties in concentration. However, there is limited data on the prevalence and pathophysiology of these cognitive issues [46]. One previous study in 28 patients with hypermobility spectrum disorder/hEDS showed cognitive impairments in patients with hEDS in terms of visuospatial problem-solving, attention, and memory compared to healthy controls (HC) [4]. Possible mechanisms of cognitive impairment include pain [79] and orthostatic intolerance (OI) [10]. While up to 90% of patients with postural orthostatic tachycardia syndrome (POTS) report cognitive complaints [11], only a few studies showed cognitive impairments. These impairments in patients with POTS mainly comprise attention, working and short-term memory, as well as executive functioning, and were found to be position dependent with worsening in the upright position [1216]. Up 80% of patients with hEDS present with syndromes of OI, such as orthostatic hypotension (OH) or POTS [1719].

Recent evidence supports a multifactorial model of cognitive impairment in hEDS. A retrospective cohort demonstrated that 79% of patients with hEDS exhibited reduced orthostatic cerebral blood flow velocity and frequent autonomic dysfunction [20], suggesting impaired cerebral perfusion as a potential mechanism. Small fiber neuropathy (SFN) and thus pain is a frequent symptom in 60% of patients with hEDS, indicating peripheral and autonomic nerve involvement [21, 22]. Furthermore, others found significant correlations between OI symptoms and cognitive complaints, supporting the view that dysautonomia contributes to cognitive dysfunction in this population [23]. Although the precise mechanisms remain unclear, both distraction and interruption may be contributors to impaired cognition: pain may divert attentional resources and engage overlapping neural networks involved in cognitive control [24], whereas OI may transiently reduce cerebral perfusion, causing temporary lapses in attention and executive function. Recent evidence highlights the complex interplay between subjective and objective cognitive performance in hypermobile hEDS [24]. While objective cognitive functioning is largely preserved, patients frequently report fluctuating cognitive difficulties influenced by pain, fatigue, and mood. A study published in 2025 specifically examined both objective and subjective cognitive performance in patients with hEDS, capturing fluctuations over time. It found that objective cognitive functioning was largely preserved, whereas reported cognitive problems were mostly subjective and varied, influenced by pain, fatigue, and depression [25]. Changes in posture, such as standing, might further affect cognition by altering cerebral perfusion due to autonomic dysregulation. Assessing cognitive performance in both supine and upright positions might allow identification of orthostasis-related deficits in attention or processing speed. Moreover, compensatory maneuvers such as leg-crossing, which increase venous return and cerebral blood flow, could help mitigate orthostatic and cognitive symptoms [26, 27].

Thus, we investigated whether patients with hEDS have impaired cognitive function compared to HC, whether cognitive function is influenced by comorbid conditions, e.g., pain, OI, autonomic complaints, or psychological distress, and whether cognitive performance is influenced by different body positions.

Materials and methods

Screening process and study design

A priori power analysis was performed to estimate the required sample size. On the basis of this analysis, approximately 30 participants per group were deemed sufficient to detect a medium-sized effect with adequate statistical power of 0.95. This approach was considered appropriate during study planning, as detecting smaller effects would have required a substantially larger sample size.

Twenty-nine patients with hEDS and 29 HC, matched by age, gender, and educational background, were prospectively enrolled in the present pilot study between 2017 and 2020 (Fig. 1). The study was performed in compliance with relevant laws, was approved by the institution’s ethics committee (EC 031/17), and conducted in accordance with the Declaration of Helsinki (registered as NCT03681080). Every participant provided written informed consent prior to participating in the study.

Fig. 1.

Fig. 1

Flow diagram of the screening process

hEDS was clinically diagnosed by an expert on the field based on the current gold standard of diagnostic criteria for hEDS [2]. Exclusion criteria included pregnancy, implanted pacemaker or deep brain stimulation, drug abuse, and severe heart failure. Additionally, for HC, exclusion criteria comprised the use of antihypertensive medication, previous neurological or psychiatric illness, as well as previous symptoms of dizziness, history of syncope, and known iron deficiency. A detailed medical history including orthostatic history was obtained for all participants. A physical examination and assessment of the Beighton score was only undertaken on the patients. The participants were asked not to take their medication on the day of the examination. A longer break from medications that could affect cognitive abilities (e.g., stimulants, serotonin and norepinephrine reuptake inhibitors [SNRIs]) was not required, as the patients were dependent on them. For the tilt table, fasting was also required (no breakfast, no caffeine). Circulatory disorders were tested using the standardized tilt-table examination, as previously described [13]. POTS was defined according to the international guidelines as a persisting increase in heart rate (HR) of at least 30 beats/min within 10 min of orthostasis, in the absence of OH, and associated with orthostatic symptoms including palpitations, dizziness, headache, and presyncope for at least 3 months [28, 29]. OH was defined by a significant decrease in the systolic blood pressure (a drop of at least 20 mmHg) or diastolic blood pressure (a drop of at least 10 mmHg) within 3 min after tilting [28, 29].

Questionnaires

General physical and mental health was assessed by the Epworth Sleepiness Scale (ESS) [30, 31], the RAND 36-Item Health Survey [32], which was analyzed according to the German manual [33], the German version of the Composite Autonomic Symptom Score (COMPASS-31) [34, 35], the Beck Depression Inventory II (BDI II) [36], the Beck Anxiety Inventory (BAI) [37], a pain questionnaire (painDETECT) [38], and a scale that assesses symptoms of OI from lying compared to standing or prolonged standing (Winker Scale); the latter comprises ten questions rated from zero to four based on symptom frequency with a total score of 40 points [39].

Baseline cognition

At cognition baseline, we evaluated the educational level (≤ 12 years vs. > 12 years of education), administered the Performance Scale of an intelligence test, the Leistungsprüfungssystem (LPS, intelligence test) [40], the Montreal cognitive Assessment (MoCA; screening for cognitive deficits) [41], and the Test Battery for Attention (TAP; attention capacity) [42].

Main cognition

Cognitive performance during different body positions was assessed using the Stroop test (selective attention) [43], the Corsi block-tapping test (spatial short-term memory and working memory) [44], the Trail Making Test Part B forward and backwards (TMT-B; visual attention and task switching) [45], and the Wechsler Memory Scale-R (memory functions) [46].

All tests were performed in three runs with varying body positions: supine (L), standing (S), and standing with legs-crossed (SLC). The order of the positions was randomized between participants to counteract any training effects. The tests followed a standardized procedure with 5-min breaks in a supine position between each run to mitigate fatigue effects (Fig. 2). Different versions of the Stroop test were available, and we used them accordingly to minimize learning effects. For the other tests, parallel forms were not available, but body positions were randomized to further reduce potential practice effects. In the Stroop test, participants must quickly name the ink color of a word, which may conflict with the word’s meaning. Reaction time from the start to the completion of the task was recorded, with faster responses indicating better selective attention and cognitive control. The detailed procedure was described previously [13].

Fig. 2.

Fig. 2

Study protocol

Statistical analysis

Statistical analysis was performed with SPSS (version 28.0). The primary endpoints were the results of the cognitive tests (TMT-A, TMT-B, and Stroop test) measured as changes in performance between lying, standing, and cross-legged positions. To account for multiple comparisons, the alpha level was adjusted using the Bonferroni correction. Accordingly, p values < 0.0125 were regarded as statistically significant. Secondary endpoints included hemodynamic changes between different body positions. Specifically, we assessed blood pressure change (mmHg) and heart rate change (beats per minute) between lying, standing, and cross-legged positions.

Differences between HC and hEDS in normally distributed metric data were assessed using an unpaired t test. Potential differences in education, as categorical data, were assessed by the chi-square test. Post hoc t tests, investigating the significant interaction between position and group on reading time in the Stroop test, were performed. Age-based normative T-values were used for the analysis of the Stroop test. A T-score of 50 represents average performance for the respective age group. Scores above 50 indicate better-than-average performance (e.g., 60 corresponds to one standard deviation above average), while scores below 50 indicate worse-than-average performance (e.g., 40 corresponds to one standard deviation below average). A repeated-measured analysis of variance (ANOVA) was used to determine the effect of positional differences on cognitive performance. We determined the group (hEDS vs HC) as between factor and the position (L vs S vs SLC) as within factor. In addition, the analysis was performed using OI as a covariate. Pearson’s correlation analysis was performed to assess a linear relationship between the cognition tests, pain, anxiety, and depression. Results are reported as mean ± standard deviation (SD).

Results

Demographics and questionnaires

Demographic characteristics are shown in Table 1. The majority (83%) had a school education of more than 12 years. Sixteen participants (55%, 15 female, mean age 32 years) were diagnosed with OI as POTS (n = 9, 8 female, mean age 28 years) or OH (n = 7, all female, mean age 36 years). Sixteen out of 29 patients with hEDS (55%) were diagnosed with small fiber neuropathy (SFN), a prevalence comparable to that reported in other studies [21, 22]. Significant differences between hEDS and HC were observed in the self-assessment questionnaires. In contrast to HCs, the patients with hEDS reported significantly more orthostatic complaints during standing (Winker Scale EDS 27.31 ± 1.49 vs. HC 2.69 ± 0.63, p < 0.001). Although the HC had rather high COMPASS-31 score, autonomic symptom burden in hEDS was significantly higher than in HC (EDS 57.314 ± 2.51 vs. HC 15.97 ± 2.48, p < 0.001) and patients with hEDS experienced higher levels of pain (EDS 4.21 ± 2.077 vs. HC 0.54 ± 1.290, p < 0.001). In hEDS, there were a higher level of anxiety (BAI, EDS 19.14 ± 2.34 vs. HC 3.45 ± 0.4, p < 0.001) and more depressive symptoms (BDI, EDS 13.72 ± 1.92 vs. HC 6.14 ± 1.25; p = 0.002). Patients with hEDS had higher levels of daytime sleepiness (EDS 10.41 ± 1.24 vs. HC 6.79 ± 0.69; p = 0.014). Mental and physical health was significantly reduced in hEDS compared to HC in all subscales of the RAND 36-Item Health Survey, with exception of emotional role function and psychological well-being (Table 2).

Table 1.

Demographic data and autonomic evaluation of patients with hEDS compared to healthy controls (HC)

Parameter hEDS HC p value
N = 29 N = 29
Age, years 36.72 ± 1.85 35.90 ± 2.02 .764
Education (> 12 years) 24 (0.83 ± 0.07) 23 (0.79 ± 0.08) 1.000
Sex (female) 28 (0.97 ± 0.03) 28 (0.97 ± 0.03) 1.000
POTS 9 0 < .001***
OH 7 0 < .001***
SFN 16 0 < .001***
Beighton score 7.10 ± 0.31 0 < .001***

Data are presented as the frequency and/or mean ± standard deviation

POTS postural orthostatic tachycardia syndrome, OH orthostatic hypotension, SFN small fiber neuropathy

*** p < .001

Table 2.

Comparison of the clinical data of the preliminary studies of patients with hEDS compared to healthy controls (HC)

Parameter hEDS HC p value
Preliminary studies N = 29 N = 29
Winker Scale 27.31 ± 1.49 2.69 ± 0.63 < .001***
ESS 10.41 ± 1.24 6.79 ± 0.69 .014*
COMPASS-31 57.31 ± 2.51 15.97 ± 2.48 < .001 ***
BDI 13.72 ± 1.92 6.14 ± 1.25 .002**
BAI 19.14 ± 2.34 3.45 ± 0.84 < .001***
Pain questionnaire (NRS) 4.21 ± 2.077 (1 NT) 0.54 ± 1.290 (1 NT) < .001***
RAND 36: Physical function 40.69 ± 3.65 88.97 ± 3.19 < .001***
RAND 36: Physical role function 5.17 ± 2.28 87.93 ± 5.49 < .001***
RAND 36: Physical pain 24.93 ± 3.86 91.79 ± 3.45 < .001***
RAND 36: General health 20.79 ± 2.24 75.83 ± 3.92 < .001***
RAND 36: Vitality 24.31 ± 3.41 57.76 ± 3.63 < .001***
RAND 36: Social functional capacity 40.52 ± 4.75 90.52 ± 3.91 < .001***
RAND 36: Emotional role function 75.86 ± 7.19 81.60 ± 5.28 .525
RAND 36: Psychological well-being 64.14 ± 4.24 76.41 ± 3.07 .023**
LPS 51.38 ± 0.82 46.68 ± 1.86 (1 NT) .026*
MOCA 27.76 ± 0.36 28.79 ± 0.20 (1 NT) .098
TAP median 38.90 ± 1.37 44.5 ± 0.34 (1 NT) .006**

Data are presented as the frequency and/or mean ± standard deviation

ESS Epworth Sleepiness Scale, COMPASS-31 German version of the Composite Autonomic Symptom Score, BDI II Beck Depression Inventory II, BAI Beck Anxiety Inventory, painDETECT pain questionnaire, NRS Numeric Rating Scale, RAND 36 German version of the RAND 36-Item Health Survey, LPS Leistungsprüfungssystem (intelligence test), MoCA Montreal cognitive Assessment, TAP Test Battery for Attention, NT not tested (i.e., there were participants who were either not tested in a test or forgot to fill out a questionnaire)

*p < .05; **p < .01; ***p < .001

Baseline cognition

Concerning cognition baseline, patients with hEDS had significantly lower reaction times in the TAP (38.9 ± 1.36; p < 0.010) compared to HC (44.5 ± 0.33), but in LPS, hEDS performed better (51.38 ± 0.81) than HC (46.68 ± 1.85; p < 0.050) (Fig. 3) These results highlighted lower attention capacity in patients with hEDS, although their intelligence was higher.

Fig. 3.

Fig. 3

Comparison of results in LPS and TAP between patients with hEDS and healthy controls (HC). *p < .05; **p < .01

Main cognition

When age-standardized T-scores were compared, patients with hEDS showed significantly lower values in the Stroop test during the standing legs-crossed condition compared to HC (hEDS 54.1 ± 1.93 vs. HC 61.6 ± 1.81; p < 0.010). Since higher T-scores indicate better performance, this result reflects impaired executive function in the hEDS group during this specific challenge (Table 3, Fig. 4). The robust ANOVA showed no influence of the position in the whole study group (HC and hEDS). There was a significant interaction between groups and positions [F(2, 112) = 3.221, p < 0.044], indicating that the executive functioning measured by the Stroop test was influenced by position only in patients with hEDS (Fig. 4). Further, the post hoc tests revealed a significant lower performance during the Stroop test in the legs-crossed position compared to the supine position in patients with hEDS only (Table 4). After controlling for the condition of OI (patients with POTS or OH), the position effect did not remain significant [F(2, 110) = 1642, p < 0.198].

Table 3.

Test results of the main examination of the patients with hEDS compared with the healthy controls

Main investigation hEDS HC p value
N = 29 N = 29
Stroop test (L) 56.90 ± 1.52 59.38 ± 1.263 .215
Stroop test (S) 54.83 ± 2.096 59.41 ± 1.383 .074
Stroop test (SLC) 54.10 ± 1.936 61.62 ± 1.816 .006**
Corsi block-tapping test (L) 5.24 ± 0.183 5.31 ± 0.223 .812
Corsi block-tapping test (S) 5.07 ± 0.192 5.28 ± 0.185 .441
Corsi block-tapping test (SLC) 5.03 ± 0.23 5.48 ± 0.190 .138
TMTB (L) 44.72 ± 1.139 46.69 ± 1.178 .235
TMTB (S) 43.66 ± 1.375 46.76 ± 1.266 .102
TMTB (SLC) 45.00 ± 1.081 48.24 ± 1.125 .042*
WMS-R (L)-(f) 51.72 ± 1.189 47.38 ± 1.906 .105
WMS-R (L)-(b) 46.55 ± 1.424 46.21 ± 2.064 .891
WMS-R (S)-(f) 49.45 ± 1.982 46.48 ± 1.849 .279
WMS-R (S)-(b) 46.38 ± 1.756 46.86 ± 1.947 .855
WMS-R (SLC)-(f) 49.00 ± 2.115 45.10 ± 2.393 .228
WMS-R (SLC)-(b) 44.97 ± 1.701 44.83 ± 2.169 .960

Data are presented as mean ± standard deviation

TMT-B Trail Making Test Part B forward and backwards, WMS-R Wechsler Memory Scale-R (memory functions), L supine, S standing, SLC standing with legs-crossed, f forward, b backwards

*p < .05; **p < .01

Fig. 4.

Fig. 4

Results of Stroop test in the different positions. In comparison hEDS vs. HC. *p < .05; **p < .01

Table 4.

Post hoc t tests investigating the significant interaction between position and group on reading time in the Stroop test

Differences hEDS HC p value
Stroop L − S 2.07 ± 1.844 − 0.03 ± 1.029 .323
Stroop L − SLC 2.79 ± 1.696 − 2.24 ± 1.132 .017*
Stroop S − SLC 0.72 ± 1.269 − 2.21 ± 1.296 .112

Data are presented as mean ± standard deviation

Different body positioning: L supine, S standing, SLC standing with legs-crossed

*p < . 05

In the context of hEDS, the correlation analysis revealed significant interactions between cognitive performance and comorbid conditions, particularly pain. Higher levels of pain strongly correlated with increased scores on the Winker (|r| = 0.584, p < 0.001) and COMPASS (|r| = 0.584, p < 0.001) assessments. Conversely, there were weak negative correlations between pain and cognitive performance across several tasks, including the LPS (|r| = − 0.308, p = 0.047), Stroop (|r| = −0.216, p = 0.125), SLC (|r| = − 0.279, p = 0.048), WMSR (|r| = − 0.353, p = 0.012), and block-tapping test (|r| = − 0.335, p = 0.029).

Discussion

In this pilot study, we found that patients with hEDS exhibited impaired cognitive function compared to HC. Particularly executive function and attentional capacity were impaired while patients with hEDS were in a standing legs-crossed position. Notably, despite patients with hEDS demonstrating higher intelligence than HC, these impairments were evident. This is the first study to demonstrate such detailed cognitive deficits in a homogenous group of patients with hEDS.

Although previous studies with patients with hEDS found no influence of pain or depression on cognitive outcomes [4], our findings suggest a potential link between cognitive function and comorbid conditions. Patients with hEDS reported significantly more autonomic symptoms, anxiety, pain, and daytime sleepiness, as well as poorer mental and physical health than HC, highlighting the profound impact of hEDS on daily functioning and the disabling nature of the condition. Furthermore, 55% of our hEDS cohort had a SFN, suggesting that pain and autonomic dysfunction associated with SFN could potentially contribute to the cognitive difficulties observed in this population. Second, moderate to strong positive correlations were found between reported pain and higher scores on the Winker and COMPASS assessments, indicating an association between pain and increased autonomic and orthostatic symptoms in these patients. Third, there were weak negative correlations between pain and performance on several cognitive tasks, suggesting a possible influence of pain on cognitive impairment. However, despite these findings, the correlations between pain and cognition were not substantial across all cognitive tasks. Previous studies in non-EDS cohorts have demonstrated an impact of pain on cognition [79], but similar research in hEDS is limited. One recent study found that pain, fatigue, and depression primarily impacted subjective cognitive complaints, while objective cognitive performance was largely preserved [25]. This may help explain why patients with hEDS often score well on intelligence tests and do not consistently perform worse than HC. Consequently, the extent to which pain influences both autonomic symptoms and cognition in hEDS remains unclear and warrants further investigation.

OI also influenced cognitive performance in patients with hEDS, particularly those diagnosed with POTS. In contrast to HC and patients with POTS, as shown by [13], the legs-crossed standing position impaired executive function in patients with hEDS rather than improving it. Interestingly, in the TMT-B, HC appeared to take longer during the standing cross-legged condition than in patients with hEDS, which contrasts with the Stroop results, where patients with hEDS performed worse in the same posture. Notably, the robust ANOVA did not show an overall effect. Although patients with hEDS showed worse Stroop performance in the standing legs-crossed condition compared to HC, Stroop scores for both groups remained within normative ranges, suggesting that these statistically significant differences may not reflect clinically meaningful impairment and should be interpreted with caution. These findings might suggest that the effects of posture and compensatory maneuvers on executive function may be quite complex. One possible factor is that many patients with hEDS are clinically highly cognitively capable, which may mitigate the attentional demands of leg-crossing. In addition, traits associated with autism spectrum conditions—which are more prevalent in hEDS—may confer strengths in selective attention and executive control, potentially influencing performance on tasks such as the TMT-B. On the other hand, fluctuations in objective cognition might also explain these findings. Thus, these observations highlight both individual variability and the need for caution when interpreting the cognitive effects of postural interventions.

During the task, many patients with hEDS reported difficulty in maintaining the legs-crossed standing posture. Current literature suggests that the standing legs-crossed position can be distracting, as cognitive and motor functions compete for limited attentional resources [47, 48]. In hEDS, this posture may constitute a more complex motor task due to joint hypermobility, instability, and impaired proprioception [49, 50]. The additional motor control and balance demands likely increase attentional load, which can offset or even override the potential cognitive benefits from improved orthostatic perfusion. This may explain why patients with hEDS do not show cognitive improvement in the legs-crossed position, unlike patients with, for example, POTS alone, for whom the maneuver primarily alleviates orthostatic stress without adding substantial motor demands. It might be interesting to include proprioception-specific tests in future studies.

Additionally, the effect of compression garments and physiotherapy on cognition in hEDS could be tested further. Some past studies have shown that compression garments can both relieve pain and improve proprioception [51, 52]. It was also shown that the effect could be increased with additional physiotherapy [52].

The small sample size in this study limits the ability to conduct detailed subgroup analyses or thoroughly explore the relationship between OI and cognition. The washout period would have been too short to fully remove the influence of medications potentially affecting cognition (e.g., stimulants, SNRIs). A potential limitation of our study is the dichotomous reporting of educational level rather than using actual years of education. Given the known impact of educational attainment on cognitive performance, this should be considered when interpreting our results and addressed in future studies. Nonetheless, this is the first study to specifically investigate cognitive performance in patients with hEDS under various conditions, compared to HC. Further studies are needed to better understand these relationships and their clinical implications.

Conclusion

In this pilot case–control study, patients with hEDS showed indications of impaired cognitive performance compared to HC, particularly in selected domains such as executive function and attention. This occurred despite patients with hEDS displaying a higher intelligence profile. Cognitive performance was closely associated with pain and autonomic symptoms, particularly under orthostatic conditions. Notably, tasks such as standing legs-crossed impaired executive function in patients with hEDS, rather than improving it, as observed in other populations. It must be taken into account that only certain aspects of cognition were assessed in this study, and conclusions should therefore be interpreted with caution. On the basis of our results, future studies should investigate whether interventions such as wearing compression garments and physiotherapy could improve not only proprioception but also cognition. In addition, symptoms such as pain, depression, and fatigue should be treated appropriately to stabilize cognitive functioning. These findings underscore the need for further research into the relationship between orthostatic intolerance, pain, and cognitive function in patients with hEDS.

Acknowledgements

The authors would like to thank all patients and controls for their consent and participation in this study.

Author contributions

Conceptualization by A.M., J.T., B.F. J.B.S. Funding acquisition by A.M. Data acquisition by K.M., J.T., L.S. and A.M. Formal analysis by K.M. and J.T. Interpretation of the data was performed by K.M., J.T. and A.M. Writing – original draft by K.M. Writing—review and editing K.M., J.T. B.M., J.B.S. and A.M. All authors read, commented and approved the final manuscript.

Funding

Open Access funding enabled and organized by Projekt DEAL. This work was supported in Part By a grant from Standing Up to POTS, Inc. (2018–2020). The organization played no role in the study design, in the collection, analysis, and interpretation of the data, in the writing of the report and in the decision to submit the article for publication.

Data availability

Anonymized data and the full trial protocol will be shared by reasonable request from the corresponding author.

Declarations

Conflict of interest

On behalf of all authors, the corresponding author reports there are no conflict of interest.

Footnotes

ClinicalTrials.gov (NCT03681080)

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Castori M (2012) Ehlers-danlos syndrome, hypermobility type. An underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations. ISRN Dermatol. 10.5402/2012/751768 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J et al (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 175(1):8–26. 10.1002/ajmg.c.31552 [DOI] [PubMed] [Google Scholar]
  • 3.Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type). Clinical description and natural history. Am J Med Genet C Semin Med Genet 175(1):48–69. 10.1002/ajmg.c.31538 [DOI] [PubMed] [Google Scholar]
  • 4.Baeza-Velasco C, Bourdon C, Polanco-Carrasco R, Jouvencel Md, Gely-Nargeot M-C, Gompel A, Hamonet C (2017) Cognitive impairment in women with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type. Rheumatol Int 37(6):937–939. 10.1007/s00296-017-3659-8 [DOI] [PubMed] [Google Scholar]
  • 5.Rombaut L, Malfait F, Paepe Ad, Rimbaut S, Verbruggen G, Wandele Id, Calders P (2011) Impairment and impact of pain in female patients with Ehlers-Danlos syndrome. A comparative study with fibromyalgia and rheumatoid arthritis. Arthritis Rheum 63(7):1979–1987. 10.1002/art.30337 [DOI] [PubMed] [Google Scholar]
  • 6.Voermans NC, Knoop H, van de Kamp N, Hamel BC, Bleijenberg G, van Engelen BG (2010) Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos syndrome. Semin Arthritis Rheum 40(3):267–274. 10.1016/j.semarthrit.2009.08.003 [DOI] [PubMed] [Google Scholar]
  • 7.Mazza S, Frot M, Rey AE (2018) A comprehensive literature review of chronic pain and memory. Prog Neuropsychopharmacol Biol Psychiatry 87:183–192. 10.1016/j.pnpbp.2017.08.006 [DOI] [PubMed] [Google Scholar]
  • 8.Moore DJ, Meints SM, Lazaridou A, Johnson D, Franceschelli O, Cornelius M et al (2019) The effect of induced and chronic pain on attention. J Pain 20(11):1353–1361. 10.1016/j.jpain.2019.05.004 [DOI] [PubMed] [Google Scholar]
  • 9.Moriarty O, McGuire BE, Finn DP (2011) The effect of pain on cognitive function. A review of clinical and preclinical research. Prog Neurobiol 93(3):385–404. 10.1016/j.pneurobio.2011.01.002 [DOI] [PubMed] [Google Scholar]
  • 10.Stephan DN (2018) Influences of postural control on cognitive control in task switching. Front Psychol 9:1153. 10.3389/fpsyg.2018.01153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE et al (2019) The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med 286(4):438–448. 10.1111/joim.12895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Anderson JW, Lambert EA, Sari CI, Dawood T, Esler MD, Vaddadi G, Lambert GW (2014) Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Front Physiol 5:230. 10.1002/hup.923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Maier A, Schopen L, Thiel JC, Müller K, Fimm B, Schulz JörgB (2023) Cognitive functioning in postural orthostatic tachycardia syndrome among different body positions. A prospective pilot study (POTSKog study). Clin Auton Res 33(4):459–468. 10.1007/s10286-006-0365-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mathias CJ, Owens A, Iodice V, Hakim A (2021) Dysautonomia in the Ehlers-Danlos syndromes and hypermobility spectrum disorders-with a focus on the postural tachycardia syndrome. Am J Med Genet C Semin Med Genet 187(4):510–519. 10.1002/ajmg.c.31951 [DOI] [PubMed] [Google Scholar]
  • 15.Raj V, Haman KL, Raj SR, Byrne D, Blakely RD, Biaggioni I et al (2009) Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry 80(3):339–344. 10.1136/jnnp.2008.144360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Raj V, Opie M, Arnold AC (2018) Cognitive and psychological issues in postural tachycardia syndrome. Auton Neurosci 215:46–55. 10.1016/j.autneu.2018.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Celletti C, Camerota F, Castori M, Censi F, Gioffrè L, Calcagnini G, Strano S (2017) Orthostatic intolerance and postural orthostatic tachycardia syndrome in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Neurovegetative dysregulation or autonomic failure? Biomed Res Int 2017:9161865. 10.1155/2017/9161865 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Igharo D, Thiel JC, Rolke R, Akkaya M, Weis J, Katona I et al (2022) Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes. Eur J Neurol 30(3):719–728. 10.1111/ene.15649 [DOI] [PubMed] [Google Scholar]
  • 19.Wandele Id, Rombaut L, Backer Td, Peersman W, Da Silva H, Mits Sd et al (2016) Orthostatic intolerance and fatigue in the hypermobility type of Ehlers-Danlos syndrome. Rheumatology (Oxford) 55(8):1412–1420. 10.1093/rheumatology/kew032 [DOI] [PubMed] [Google Scholar]
  • 20.Novak P, Systrom DM, Marciano SP, Witte A, Warren A, Felsenstein D, Giannetti MP, Hamilton MJ, Nicoloro-SantaBarbara J, Castells M, Farhad K, Pilgrim DM, Mullally WJ, Fishman MC, Milunsky JM, Milunsky A, Krier J (2025) Hypermobile Ehlers-Danlos syndrome: cerebrovascular, autonomic and neuropathic features. Am J Med Open 14:100111. 10.1016/j.ajmo.2025.100111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Igharo D, Thiel JC, Rolke R, Akkaya M, Weis J, Katona I, Schulz JB, Maier A (2023) Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes. Eur J Neurol 30(3):719–728. 10.1111/ene.15649 [DOI] [PubMed] [Google Scholar]
  • 22.Cazzato D, Castori M, Lombardi R, Caravello F, Bella ED, Petrucci A, Grammatico P, Dordoni C, Colombi M, Lauria G (2016) Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology 87(2):155–159. 10.1212/WNL.0000000000002847 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tariq A, Khan MN, Jamali AG, Amir Basra M, Mahato A, Imran SM, Mohsin Z, Singla S, Mirani IK, Asmat U, Malik H (2025) Association between orthostatic intolerance symptoms and cognitive complaints in hypermobile Ehlers-Danlos syndrome (hEDS) and joint hypermobility spectrum disorder (JHSD): a cross-sectional analysis. Cureus 17(6):e86123. 10.7759/cureus.86123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Eccles JA, Beacher FD, Gray MA, Jones CL, Minati L, Harrison NA, Critchley HD (2012) Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms. Br J Psychiatry 200(6):508–509. 10.1192/bjp.bp.111.092460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sousa A, Jung MK, Allera A, Riley B (2025) Neuropsychological function and the relationship between subjective cognition, objective cognition, and symptoms in hypermobile Ehlers-Danlos syndrome. Brain Behav 15(6):e70603. 10.1002/brb3.70603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fu Qi, Levine BD (2018) Exercise and non-pharmacological treatment of POTS. Auton Neurosci 215:20–27. 10.1016/j.autneu.2018.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wieling W, van Dijk N, Thijs RD, Lange FJde, Krediet CTP, Halliwill JR (2015) Physical countermeasures to increase orthostatic tolerance. J Intern Med 277(1):69–82. 10.1111/joim.12249 [DOI] [PubMed] [Google Scholar]
  • 28.Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72. 10.1007/s10286-011-0119-5 [DOI] [PubMed] [Google Scholar]
  • 29.Sheldon RS, Grubb BP, Olshansky B, Shen W-K, Calkins H, Brignole M et al (2015) 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart rhythm 12(6):41–63. 10.1016/j.hrthm.2015.03.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fragebogen zur Tagesschläfrigkeit (Epworth Sleepiness Scale). http://dgsm-archiv.not-only-pixel.de/downloads/fachinformationen/frageboegen/ess.pdf. Accessed 03 Sept 2012
  • 31.Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545. 10.1093/sleep/14.6.540 [DOI] [PubMed] [Google Scholar]
  • 32.Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-item health survey 1.0. Health Econ 2(3):217–227. 10.1002/hec.4730020305 [DOI] [PubMed] [Google Scholar]
  • 33.Bullinger M, Kirchberger I (Hg.) (1998) SF-36. Fragebogen zum Gesundheitszustand: Göttingen: Hogrefe.
  • 34.Hilz M-J, Wang R, Singer W (2022) Validation of the composite autonomic symptom score 31 in the German language. Neurol Sci 43(1):365–371. 10.1371/journal.pone.0180744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31. a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 87(12):1196–1201. 10.1016/j.mayocp.2012.10.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hornke, Lutz F (2011) In: Persönlichkeitsdiagnostik. [Vollst. Neuausg.]. Göttingen [u.a.]: Hogrefe (Enzyklopädie der Psychologie : Themenbereich B, Methodologie und Methoden : Serie 2, Psychologische Diagnostik, 4)
  • 37.Beck AT. Beck Anxiety Inventory (BAI). 1990. German adaptation by Margraf J, Ehlers A. Berlin: Springer; 2007
  • 38.Freynhagen R, Baron R, Gockel U, Tölle TR (2006) PainDETECT. A new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22(10):1911–1920. 10.1185/030079906X132488 [DOI] [PubMed] [Google Scholar]
  • 39.Haensch C-A, Jost W (Hg.) (2009) In: Das autonome Nervensystem. Grundlagen, Organsysteme und Krankheitsbilder. 1. Aufl. s.l.: Kohlhammer Verlag
  • 40.Lepach AC, Petermann F (2012) Gedächtnisdiagnostik mit der Wechsler Memory Scale – Fourth Edition. Z Neuropsychol 23(3):123–132. 10.1024/1016-264X/a000070 [Google Scholar]
  • 41.Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. 10.1111/j.1532-5415.2005.53221.x [DOI] [PubMed] [Google Scholar]
  • 42.Fiene M, Bittner V, Fischer J, Schwiecker K, Heinze H-J, Zaehle T (2015) Untersuchung der Simulationssensibilität des Alertness-Tests der Testbatterie zur Aufmerksamkeitsprüfung (TAP). Z Neuropsychol 26(2):73–86. 10.1024/1016-264X/a000125 [Google Scholar]
  • 43.Uttl B, Graf P (1997) Color-word Stroop test performance across the adult life span. J Clin Exp Neuropsychol 19(3):405–420. 10.1080/01688639708403869 [DOI] [PubMed] [Google Scholar]
  • 44.Kessels RP, van Zandvoort MJ, Postma A, Kappelle LJ, Haan EHde (2000) The Corsi block-tapping task. Standardization and normative data. Appl Neuropsychol 7(4):252–258. 10.1207/S15324826AN0704_8 [DOI] [PubMed] [Google Scholar]
  • 45.Arnett JA, Labovitz SS (1995) Effect of physical layout in performance of the Trail Making Test. Psychol Assess 7(2):220–221. 10.1037/1040-3590.7.2.220 [Google Scholar]
  • 46.Jones G, Macken B (2015) Questioning short-term memory and its measurement. Why digit span measures long-term associative learning. Cognition 144:1–13. 10.1016/j.cognition.2015.07.009 [DOI] [PubMed] [Google Scholar]
  • 47.Johannsen L, Stephan DN, Straub E, Döhring F, Kiesel A, Koch I, Müller H (2023) Assessing the influence of cognitive response conflict on balance control. An event-related approach using response-aligned force-plate time series data. Psychol Res. 10.1016/S0966-6362(01)00156-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Woollacott MH (2000) Systems contributing to balance disorders in older adults. J Gerontol A Biol Sci Med Sci 55(8):424. 10.1093/gerona/55.8.m424 [DOI] [PubMed] [Google Scholar]
  • 49.Ghibellini G, Brancati F, Castori M (2015) Neurodevelopmental attributes of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Update and perspectives. Am J Med Genet C Semin Med Genet. 10.1002/ajmg.c.31424 [DOI] [PubMed] [Google Scholar]
  • 50.Gibbs J, Appleton J, Appleton R (2007) Dyspraxia or developmental coordination disorder? Unravelling the enigma. Arch Dis Child 92(6):534–539. 10.1136/adc.2005.088054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Benistan K, Pontier B, Leblond C, Flageul O, Le Guicher G, Enjalbert M, Gillas F (2023) The effectiveness of compression garments for reducing pain in non-vascular ehlers-danlos syndromes. A prospective observational cohort study. Healthcare Basel, Switzerland. 10.1186/s13102-020-00230-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Benistan K, Foy M, Gillas F, Genet F, Kane M, Barbot F et al (2024) Effects of compression garments on balance in hypermobile Ehlers-Danlos syndrome. A randomized controlled trial. Disabil Rehabil 46(9):1841–1850. 10.1080/09638288.2023.2209742 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Anonymized data and the full trial protocol will be shared by reasonable request from the corresponding author.


Articles from Clinical Autonomic Research are provided here courtesy of Springer

RESOURCES